Worth reading
49Recurring
Scored from 4 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Conditional
How definitive the wording is.Who is moving to which position
Resolved 26 March 2026Incoming appointee
6 itemsScheduled Appointment DateEffective 20 May 2026. The appointments are scheduled to be formally determined following approval at the annual general meeting of shareholders of 株式会社メディカル一光 scheduled for 20 May 2026 and at the subsequent meeting of the Board of Directors.
Eguchi Kanichi (江口 寛一)
Previous positionRepresentative Director, President; Head of Western Headquarters
New positionRepresentative Director, President; Head of Western Headquarters
Toyama Kunihiko (遠山 邦彦)
Previous positionRepresentative Director and Executive Vice President; Head of Administration Headquarters
New positionRepresentative Director and Executive Vice President; Head of Administration Headquarters
Yamashita Hirofumi (山下 裕文)
Previous positionDirector; Head of Pharmacy Business Headquarters and Head of First Business Division
New positionDirector; Head of Pharmacy Business Headquarters and Head of First Business Division
Yoshizawa Yusuke (吉澤 佑輔)
Previous positionDirector; Head of Eastern Headquarters and Head of Kanto Business Division
New positionDirector; Head of Eastern Headquarters and Head of Kanto Business Division
Fuchida Yukihiro (渕田 幸裕)
Previous positionOutside directors
New positionOutside directors
Wada Sora (和田 そら)
Previous positionOutside directors
New positionOutside directors
Departing officer
1 itemDate of departureAt the conclusion of the annual general meeting of shareholders on 20 May 2026
Kubo Junichi (久保順一)Next role stated
Former PositionDirectors
New positionRetirement
“Next role stated” means the document names the position the person holds after stepping down. It does not necessarily mean they are leaving the company.
Reason for departure
Retirement upon expiration of term
Whether the incumbent will remain in office (whether they will retain their position)
Will not remain on the Board of Directors
Directors after the change6Number
Shareholders’ meeting approvalRequired. Approval at the annual general meeting of shareholders of 株式会社メディカル一光 scheduled for 20 May 2026 and at the subsequent meeting of the Board of Directors
| Item | Details |
|---|---|
| Resolution date | 26 March 2026 |
| Scheduled Appointment Date | Effective 20 May 2026. The appointments are scheduled to be formally determined following approval at the annual general meeting of shareholders of 株式会社メディカル一光 scheduled for 20 May 2026 and at the subsequent meeting of the Board of Directors. |
| Date of departure | At the conclusion of the annual general meeting of shareholders on 20 May 2026 |
| Name of appointee | Eguchi Kanichi (江口 寛一), Toyama Kunihiko (遠山 邦彦), Yamashita Hirofumi (山下 裕文), Yoshizawa Yusuke (吉澤 佑輔), Fuchida Yukihiro (渕田 幸裕), Wada Sora (和田 そら) |
| Appointee's new position | Representative Director, President; Head of Western Headquarters, Representative Director and Executive Vice President; Head of Administration Headquarters, Director; Head of Pharmacy Business Headquarters and Head of First Business Division, Director; Head of Eastern Headquarters and Head of Kanto Business Division, Outside directors, Outside directors |
| Appointee's previous position | Representative Director, President; Head of Western Headquarters, Representative Director and Executive Vice President; Head of Administration Headquarters, Director; Head of Pharmacy Business Headquarters and Head of First Business Division, Director; Head of Eastern Headquarters and Head of Kanto Business Division, Outside directors, Outside directors |
| Name of departing officer | Kubo Junichi (久保順一) |
| Former position of departing officer | Directors |
| New position of departing officer | Retirement |
| Reason for departure | Retirement upon expiration of term |
| Whether the incumbent will remain in office | Will not remain on the Board of Directors |
| Number of directors after the change | 6 (including 2 outside directors) |
| Subject to Approval by the General Meeting of Shareholders | Required. Approval at the annual general meeting of shareholders of 株式会社メディカル一光 scheduled for 20 May 2026 and at the subsequent meeting of the Board of Directors |
Items this document does not state (8)
Appointee's date of birthYear the appointee joined the CompanyNumber of shares held by the appointeeReason for changeReasons for appointmentFiling as an independent officerDetails of organizational changesChange in Corporate Governance Structure
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Director Kubo Junichi (久保順一) will leave office when his term expires at the conclusion of the annual general meeting of shareholders scheduled for 20 May 2026. The company has provided no separate reasons for the other personnel changes.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.